Home/Filings/4/0001104659-23-028498
4//SEC Filing

Atkisson Erik 4

Accession 0001104659-23-028498

CIK 0001724979other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:07 PM ET

Size

5.6 KB

Accession

0001104659-23-028498

Insider Transaction Report

Form 4
Period: 2023-03-02
Atkisson Erik
General Counsel and CCO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-02+120,000120,000 total
    Exercise: $9.34Exp: 2033-03-02Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 120,000 shares of the Issuer's common stock, one quarter of which will vest on February 21, 2024, with the remaining three quarters vesting in equal monthly installments through February 21, 2027, subject to the Reporting Person's continued service to the Issuer.

Issuer

Rain Oncology Inc.

CIK 0001724979

Entity typeother

Related Parties

1
  • filerCIK 0001885915

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:07 PM ET
Size
5.6 KB